Blue Earth Diagnostics Stock

blueearthdiagnostics.comBioTechFounded: 2014Funding to Date: $21.3MM

Blue Earth Diagnostics is a molecular imaging diagnostics company focused on the development and commercialization of novel PET imaging agents to inform clinical management and guide care for cancer patients in areas of unmet medical need.

Register for Details

For more details on financing and valuation for Blue Earth Diagnostics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Jonathan Allis Ph.D
Co-Founder, Board Member & Chief Executive Officer
Michael Heslop
President
Jim Martin
Chief Financial Officer
David Gauden
Chief Scientific Officer
Ted Broadbent Ph.D
Global Brand Director
Matthew Miller Ph.D
Head of Imaging and Project Management
Kathy Nagle Ph.D
Head of Manufacture/Supply Chain and Quality Assurance
Peter Gardiner
Chief Medical Officer
Martin Murphy Ph.D
Chairman

Board Members

Elisa Petris Ph.D
Syncona
Jonathan Allis Ph.D
Martin Murphy Ph.D

Other companies like Blue Earth Diagnostics in the BioTech sector

Sector
Last Round Est. Valuation
$143.8MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$138.75MM
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$289.42MM
Sector
Last Round Est. Valuation
$1.08B

News

Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced that a definitive agreement has been signed for Bracco Imaging S.p.A.